Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer

One of the most challenging aspects of lung cancer therapy is the rapid acquisition of multidrug-resistant (MDR) phenotype. One effective approach would be to identify and downregulate resistance-causing genes in tumors using small interfering RNAs (siRNAs) to increase the sensitivity of tumor cells...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ganesh, Shanthi, Iyer, Arun K, Weiler, Jan, Morrissey, David V, Amiji, Mansoor M
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2013
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3731892/
https://ncbi.nlm.nih.gov/pubmed/23900224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mtna.2013.29
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak